Compound Detail
CHEMBL4640206
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4640206 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | OYSIWQHFVXULED-UHFFFAOYSA-N |
3
Targets
6
Activities
1
Assay Types
2
PK Parameters
7
Publications
0
Known Names
Molecular Properties
419.3
MW (Da)
5.52
ALogP
4
HBA
1
HBD
60.5
PSA (Ų)
0.35
QED
1
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 9.51
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Plasmodium falciparum CHEMBL364 | IC50 | 9.51 | 8.795 | 0.3 | 4 |
| Plasmodium berghei CHEMBL612653 | IC50 | 9.35 | 9.35 | 0.5 | 1 |
| HepG2 CHEMBL395 | IC50 | 6.12 | 6.12 | 755.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| T1/2 | 1.0 | hr | Homo sapiens |
| T1/2 | 0.8333 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Plasmodium falciparum | IC50 | = | 0.31 | nM | 9.51 | Antimalarial activity against multidrug resistant Plasmodium falciparum Dd2 infe... | 32390431 |
| Plasmodium berghei | IC50 | = | 0.45 | nM | 9.35 | Antimalarial activity against luciferase-expressing Plasmodium berghei ANKA 676m... | 32390431 |
| Plasmodium falciparum | IC50 | = | 0.65 | nM | 9.19 | Antimalarial activity against multidrug resistant Plasmodium falciparum D6 infec... | 32390431 |
| Plasmodium falciparum | IC50 | = | 1.6 | nM | 8.8 | Antimalarial activity against multidrug resistant Plasmodium falciparum 7G8 infe... | 32390431 |
| Plasmodium falciparum | IC50 | = | 21.0 | nM | 7.68 | Antimalarial activity against multidrug resistant Plasmodium falciparum Tm90-C2B... | 32390431 |
| HepG2 | IC50 | = | 755.0 | nM | 6.12 | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability m... | 32390431 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32390431 | 10.1021/acs.jmedchem.0c00539 | Plasmodium berghei | 5 |
| 32390431 | 10.1021/acs.jmedchem.0c00539 | Plasmodium falciparum | 4 |
| 32390431 | 10.1021/acs.jmedchem.0c00539 | ADMET | 4 |
| 32390431 | 10.1021/acs.jmedchem.0c00539 | Plasmodium yoelii | 4 |
| 32390431 | 10.1021/acs.jmedchem.0c00539 | HepG2 | 1 |
| 32390431 | 10.1021/acs.jmedchem.0c00539 | Unchecked | 1 |
| 32390431 | 10.1021/acs.jmedchem.0c00539 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
Data from ChEMBL 36 via Core Engine